Dr. Ford is a medical oncologist and geneticist at Stanford, devoted to studying the genetic basis of breast and GI cancer development, treatment and prevention in families and populations.  Dr. Ford graduated in 1984 from Yale University where he later received his M.D. degree from the School of Medicine in 1989.  He was an internal medicine resident and oncology fellow at Stanford, and joined the faculty in 1998.  He is currently Professor of Medicine (Oncology) and Genetics, Director of the Stanford Cancer Genetics Clinic and the Cancer Genomics Program at the Stanford Medicine.

Dr. Ford’s clinical interests include the diagnosis and treatment of patients with a hereditary pre-disposition to cancer.  He runs the Stanford Cancer Genetics Clinic, that sees patients for genetic counseling and testing of hereditary cancer syndromes for prevention and early diagnosis of cancer in high-risk individuals and populations.  He is also Director of Stanford’s Cancer Genomics Program, performing next-generation tumor profiling to identify novel genetic targets for personalized targeted therapies, directs the Stanford Molecular Tumor Board, and is a PI on numerous trials of genomically targeted therapies, including the national Combo-MATCH trial.

Dr. Ford is devoted to the training and mentoring of future scientists and physician-investigators. He is the Associate Director for Training and Education for the Stanford Cancer Institute, and a founding advisor for the Stanford Master’s Program in Genetic Counseling.  He is also a current and former editor of numerous scientific journals, including Cancer Research, DNA Repair, and PLoS Genetics, and he is the founding Editor-in-Chief of JCO Precision Oncology.